Leukemia Treatment Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: LA0CC91B61C1EN
Market Monitor Global

Abstracts

Leukemia Treatment Drugs is used to cure Leukemia.

This report contains market size and forecasts of Leukemia Treatment Drugs in Global, including the following market information:

Global Leukemia Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Leukemia Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gleevec Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Leukemia Treatment Drugs include GSK, Pfizer, Novartis AG, Roche, Celgene, Biogen, Genzyme Corporation, Eisai C. and Bristol Myers Squibb Company (BMS). etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leukemia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Leukemia Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Leukemia Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

• Gleevec
• Sapacitabine
• GA101
• Vasaroxine
• Tosedosat
• Revlimid
• Bosutinib

Global Leukemia Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Leukemia Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Global Leukemia Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Leukemia Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Leukemia Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Leukemia Treatment Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Pfizer
• Novartis AG
• Roche
• Celgene
• Biogen
• Genzyme Corporation
• Eisai C.
• Bristol Myers Squibb Company (BMS)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Leukemia Treatment Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Leukemia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LEUKEMIA TREATMENT DRUGS OVERALL MARKET SIZE

2.1 Global Leukemia Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Leukemia Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Leukemia Treatment Drugs Players in Global Market
3.2 Top Global Leukemia Treatment Drugs Companies Ranked by Revenue
3.3 Global Leukemia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Leukemia Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Leukemia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Leukemia Treatment Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Leukemia Treatment Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Leukemia Treatment Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Leukemia Treatment Drugs Market Size Markets, 2021 & 2028
  4.1.2 Gleevec
  4.1.3 Sapacitabine
  4.1.4 GA101
  4.1.5 Vasaroxine
  4.1.6 Tosedosat
  4.1.7 Revlimid
  4.1.8 Bosutinib
4.2 By Type - Global Leukemia Treatment Drugs Revenue & Forecasts
  4.2.1 By Type - Global Leukemia Treatment Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Leukemia Treatment Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Leukemia Treatment Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Leukemia Treatment Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Research Institutes
  5.1.4 Diagnostic Centers
  5.1.5 Others
5.2 By Application - Global Leukemia Treatment Drugs Revenue & Forecasts
  5.2.1 By Application - Global Leukemia Treatment Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Leukemia Treatment Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Leukemia Treatment Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Leukemia Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Leukemia Treatment Drugs Revenue & Forecasts
  6.2.1 By Region - Global Leukemia Treatment Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Leukemia Treatment Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Leukemia Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Leukemia Treatment Drugs Revenue, 2017-2028
  6.3.2 US Leukemia Treatment Drugs Market Size, 2017-2028
  6.3.3 Canada Leukemia Treatment Drugs Market Size, 2017-2028
  6.3.4 Mexico Leukemia Treatment Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Leukemia Treatment Drugs Revenue, 2017-2028
  6.4.2 Germany Leukemia Treatment Drugs Market Size, 2017-2028
  6.4.3 France Leukemia Treatment Drugs Market Size, 2017-2028
  6.4.4 U.K. Leukemia Treatment Drugs Market Size, 2017-2028
  6.4.5 Italy Leukemia Treatment Drugs Market Size, 2017-2028
  6.4.6 Russia Leukemia Treatment Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Leukemia Treatment Drugs Market Size, 2017-2028
  6.4.8 Benelux Leukemia Treatment Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Leukemia Treatment Drugs Revenue, 2017-2028
  6.5.2 China Leukemia Treatment Drugs Market Size, 2017-2028
  6.5.3 Japan Leukemia Treatment Drugs Market Size, 2017-2028
  6.5.4 South Korea Leukemia Treatment Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Leukemia Treatment Drugs Market Size, 2017-2028
  6.5.6 India Leukemia Treatment Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Leukemia Treatment Drugs Revenue, 2017-2028
  6.6.2 Brazil Leukemia Treatment Drugs Market Size, 2017-2028
  6.6.3 Argentina Leukemia Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Leukemia Treatment Drugs Revenue, 2017-2028
  6.7.2 Turkey Leukemia Treatment Drugs Market Size, 2017-2028
  6.7.3 Israel Leukemia Treatment Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Leukemia Treatment Drugs Market Size, 2017-2028
  6.7.5 UAE Leukemia Treatment Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Leukemia Treatment Drugs Major Product Offerings
  7.1.4 GSK Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.1.5 GSK Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Leukemia Treatment Drugs Major Product Offerings
  7.2.4 Pfizer Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Leukemia Treatment Drugs Major Product Offerings
  7.3.4 Novartis AG Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Leukemia Treatment Drugs Major Product Offerings
  7.4.4 Roche Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Celgene
  7.5.1 Celgene Corporate Summary
  7.5.2 Celgene Business Overview
  7.5.3 Celgene Leukemia Treatment Drugs Major Product Offerings
  7.5.4 Celgene Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.5.5 Celgene Key News
7.6 Biogen
  7.6.1 Biogen Corporate Summary
  7.6.2 Biogen Business Overview
  7.6.3 Biogen Leukemia Treatment Drugs Major Product Offerings
  7.6.4 Biogen Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.6.5 Biogen Key News
7.7 Genzyme Corporation
  7.7.1 Genzyme Corporation Corporate Summary
  7.7.2 Genzyme Corporation Business Overview
  7.7.3 Genzyme Corporation Leukemia Treatment Drugs Major Product Offerings
  7.7.4 Genzyme Corporation Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.7.5 Genzyme Corporation Key News
7.8 Eisai C.
  7.8.1 Eisai C. Corporate Summary
  7.8.2 Eisai C. Business Overview
  7.8.3 Eisai C. Leukemia Treatment Drugs Major Product Offerings
  7.8.4 Eisai C. Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.8.5 Eisai C. Key News
7.9 Bristol Myers Squibb Company (BMS)
  7.9.1 Bristol Myers Squibb Company (BMS) Corporate Summary
  7.9.2 Bristol Myers Squibb Company (BMS) Business Overview
  7.9.3 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Major Product Offerings
  7.9.4 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue in Global Market (2017-2022)
  7.9.5 Bristol Myers Squibb Company (BMS) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Leukemia Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Leukemia Treatment Drugs Market Drivers in Global Market
Table 3. Leukemia Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Leukemia Treatment Drugs in Global Market
Table 5. Top Leukemia Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Leukemia Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Leukemia Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Leukemia Treatment Drugs Product Type
Table 9. List of Global Tier 1 Leukemia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Leukemia Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Leukemia Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Leukemia Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Leukemia Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Leukemia Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Leukemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Leukemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Leukemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Leukemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Leukemia Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Leukemia Treatment Drugs Product Offerings
Table 32. GSK Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Leukemia Treatment Drugs Product Offerings
Table 35. Pfizer Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Leukemia Treatment Drugs Product Offerings
Table 38. Novartis AG Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Leukemia Treatment Drugs Product Offerings
Table 41. Roche Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Leukemia Treatment Drugs Product Offerings
Table 44. Celgene Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Biogen Corporate Summary
Table 46. Biogen Leukemia Treatment Drugs Product Offerings
Table 47. Biogen Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Genzyme Corporation Corporate Summary
Table 49. Genzyme Corporation Leukemia Treatment Drugs Product Offerings
Table 50. Genzyme Corporation Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Eisai C. Corporate Summary
Table 52. Eisai C. Leukemia Treatment Drugs Product Offerings
Table 53. Eisai C. Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Bristol Myers Squibb Company (BMS) Corporate Summary
Table 55. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Product Offerings
Table 56. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Leukemia Treatment Drugs Segment by Type in 2021
Figure 2. Leukemia Treatment Drugs Segment by Application in 2021
Figure 3. Global Leukemia Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Leukemia Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Leukemia Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Leukemia Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Leukemia Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Leukemia Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biogen Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genzyme Corporation Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eisai C. Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)